Previous close | 79.08 |
Open | 79.25 |
Bid | 78.97 x 1400 |
Ask | 79.27 x 1000 |
Day's range | 78.43 - 79.30 |
52-week range | 68.84 - 92.02 |
Volume | |
Avg. volume | 6,383,474 |
Market cap | 105.15B |
Beta (5Y monthly) | 0.78 |
PE ratio (TTM) | 25.14 |
EPS (TTM) | 3.15 |
Earnings date | 23 May 2024 |
Forward dividend & yield | 2.76 (3.49%) |
Ex-dividend date | 21 Mar 2024 |
1y target est | 94.00 |
Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.
Americans overwhelmingly say that when they think about longevity, it's more than just living longer—it's about living their healthiest, best lives. While most want to live to 90—well past the average U.S. life expectancy of 77.5 years—nearly two-thirds (66%) would choose a shorter, healthier life over a longer one with health issues. These findings, from a survey conducted by global healthcare technology leader Medtronic with Morning Consult, highlight a gap between U.S. adults' desire to live
Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic are included in this Analyst Blog.